- Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma
-
Murakami M, Fujimaki T, Asano S, Nakaguchi , Yamada SM, Hoya K, Yamazaki K, Ishida Y, Matsuno A
- KMID: 1058828
- Yonsei Med J.
- 2011 Nov;52(6):1031-1034.
- doi: 10.3349/ymj.2011.52.6.1031
High-dose methotrexate-based chemotherapy has extended survival in patients with primary central nervous system lymphoma (PCNSL). However, although salvage treatment is necessary in recurrent and refractory PCNSL, this has not been... -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging
-
Lee EK, Choi SH, Yun TJ, Kang KM, Kim TM, Lee SH, Park CK, Park SH, Kim IH
- KMID: 2344290
- Korean J Radiol.
- 2015 Dec;16(6):1341-1348.
- doi: 10.3348/kjr.2015.16.6.1341
OBJECTIVE: To determine whether histogram values of the normalized apparent diffusion coefficient (nADC) and normalized cerebral blood volume (nCBV) maps obtained in contrast-enhancing lesions detected on immediate post-operative MR imaging... -
- CITED
-
- Close
- SHARE
-
- Close
